Robin Deterding
Concepts (474)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Diseases, Interstitial | 36 | 2025 | 644 | 7.410 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 9 | 2023 | 45 | 2.240 |
Why?
| | Neuroendocrine Cells | 9 | 2020 | 32 | 2.110 |
Why?
| | Respiration Disorders | 5 | 2019 | 78 | 1.630 |
Why?
| | Bronchoalveolar Lavage Fluid | 7 | 2019 | 643 | 1.550 |
Why?
| | Hyperplasia | 12 | 2022 | 176 | 1.530 |
Why?
| | Glycogen Storage Disease | 3 | 2021 | 19 | 1.420 |
Why?
| | Lung | 30 | 2024 | 4065 | 1.200 |
Why?
| | Idiopathic Pulmonary Fibrosis | 6 | 2024 | 657 | 1.180 |
Why?
| | Child | 73 | 2025 | 21990 | 1.040 |
Why?
| | Infant | 44 | 2025 | 9566 | 1.040 |
Why?
| | Cystic Fibrosis | 7 | 2019 | 1106 | 0.930 |
Why?
| | Child, Preschool | 40 | 2025 | 11142 | 0.890 |
Why?
| | Proteomics | 6 | 2023 | 1109 | 0.870 |
Why?
| | Pediatrics | 8 | 2015 | 1074 | 0.850 |
Why?
| | Machine Learning | 2 | 2019 | 516 | 0.850 |
Why?
| | Tomography, X-Ray Computed | 17 | 2024 | 2693 | 0.780 |
Why?
| | Oxygen Inhalation Therapy | 5 | 2019 | 161 | 0.770 |
Why?
| | Bronchiectasis | 3 | 2024 | 110 | 0.700 |
Why?
| | Mutation | 14 | 2024 | 3994 | 0.700 |
Why?
| | Humans | 109 | 2025 | 138102 | 0.650 |
Why?
| | Immunologic Techniques | 1 | 2019 | 39 | 0.650 |
Why?
| | Allergy and Immunology | 1 | 2019 | 39 | 0.620 |
Why?
| | Biopsy | 15 | 2019 | 1089 | 0.610 |
Why?
| | Home Care Services | 2 | 2019 | 259 | 0.590 |
Why?
| | Asthma | 3 | 2019 | 1890 | 0.580 |
Why?
| | Nocturnal Myoclonus Syndrome | 1 | 2018 | 5 | 0.580 |
Why?
| | Respiratory Distress Syndrome, Newborn | 2 | 2019 | 104 | 0.570 |
Why?
| | Sleep Wake Disorders | 2 | 2020 | 301 | 0.570 |
Why?
| | Aptamers, Nucleotide | 1 | 2019 | 83 | 0.560 |
Why?
| | Lung Diseases | 8 | 2020 | 769 | 0.540 |
Why?
| | Respiratory Function Tests | 12 | 2024 | 560 | 0.540 |
Why?
| | Hypoxia | 4 | 2018 | 1121 | 0.530 |
Why?
| | Deoxycytosine Nucleotides | 2 | 2007 | 13 | 0.500 |
Why?
| | Uridine | 2 | 2007 | 30 | 0.500 |
Why?
| | Male | 53 | 2025 | 67984 | 0.470 |
Why?
| | Pulmonary Alveoli | 7 | 2021 | 405 | 0.460 |
Why?
| | Pulmonary Surfactants | 8 | 2013 | 104 | 0.460 |
Why?
| | Female | 52 | 2025 | 73648 | 0.450 |
Why?
| | Hypertension, Pulmonary | 7 | 2024 | 1916 | 0.450 |
Why?
| | Bronchiolitis Obliterans | 4 | 2024 | 68 | 0.440 |
Why?
| | Household Articles | 1 | 2014 | 27 | 0.420 |
Why?
| | Clinical Clerkship | 6 | 2007 | 104 | 0.420 |
Why?
| | Adolescent | 34 | 2025 | 21637 | 0.410 |
Why?
| | Disinfectants | 1 | 2014 | 41 | 0.410 |
Why?
| | Respiration, Artificial | 4 | 2021 | 639 | 0.410 |
Why?
| | Pulmonary Surfactant-Associated Protein B | 3 | 2010 | 6 | 0.410 |
Why?
| | Research | 2 | 2020 | 451 | 0.410 |
Why?
| | Growth Substances | 6 | 2000 | 148 | 0.390 |
Why?
| | Bronchiolitis | 1 | 2013 | 82 | 0.390 |
Why?
| | Retrospective Studies | 25 | 2024 | 15750 | 0.390 |
Why?
| | Esophagoscopy | 3 | 2019 | 210 | 0.360 |
Why?
| | Polyendocrinopathies, Autoimmune | 1 | 2011 | 18 | 0.360 |
Why?
| | ATP-Binding Cassette Transporters | 5 | 2014 | 120 | 0.360 |
Why?
| | Neurosecretory Systems | 3 | 2010 | 31 | 0.360 |
Why?
| | International Classification of Diseases | 1 | 2012 | 138 | 0.360 |
Why?
| | Program Development | 2 | 2018 | 367 | 0.350 |
Why?
| | Humidity | 1 | 2011 | 50 | 0.340 |
Why?
| | Potassium Channels | 1 | 2011 | 148 | 0.340 |
Why?
| | Fibroblast Growth Factors | 5 | 2000 | 177 | 0.340 |
Why?
| | Infant, Newborn | 17 | 2019 | 6140 | 0.330 |
Why?
| | Dust | 1 | 2011 | 99 | 0.330 |
Why?
| | Computer Simulation | 4 | 2018 | 987 | 0.330 |
Why?
| | Inhalation Exposure | 1 | 2011 | 106 | 0.320 |
Why?
| | Rare Diseases | 3 | 2020 | 105 | 0.320 |
Why?
| | Education, Medical, Undergraduate | 3 | 2007 | 190 | 0.320 |
Why?
| | Pulmonary Alveolar Proteinosis | 2 | 2023 | 16 | 0.320 |
Why?
| | Diagnosis, Differential | 6 | 2019 | 1490 | 0.310 |
Why?
| | Problem-Based Learning | 4 | 2006 | 92 | 0.310 |
Why?
| | Purinergic P2 Receptor Agonists | 2 | 2007 | 6 | 0.300 |
Why?
| | Eosinophilic Esophagitis | 3 | 2019 | 325 | 0.300 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2024 | 625 | 0.290 |
Why?
| | Immunologic Factors | 2 | 2011 | 239 | 0.290 |
Why?
| | Pulmonary Fibrosis | 2 | 2024 | 399 | 0.290 |
Why?
| | Tomography | 2 | 2018 | 41 | 0.280 |
Why?
| | Autoimmune Diseases | 3 | 2024 | 452 | 0.280 |
Why?
| | Lung Injury | 1 | 2011 | 218 | 0.280 |
Why?
| | Curriculum | 2 | 2007 | 1003 | 0.270 |
Why?
| | Case-Control Studies | 6 | 2019 | 3569 | 0.260 |
Why?
| | Cytokines | 2 | 2019 | 2079 | 0.260 |
Why?
| | Respiratory Tract Diseases | 2 | 2019 | 180 | 0.260 |
Why?
| | Practice Guidelines as Topic | 4 | 2024 | 1557 | 0.250 |
Why?
| | Gastrointestinal Diseases | 2 | 2018 | 207 | 0.240 |
Why?
| | Pneumonia | 2 | 2019 | 638 | 0.240 |
Why?
| | Genetic Testing | 2 | 2025 | 458 | 0.230 |
Why?
| | Vital Capacity | 2 | 2024 | 302 | 0.230 |
Why?
| | United States | 12 | 2025 | 15028 | 0.230 |
Why?
| | Double-Blind Method | 3 | 2023 | 1922 | 0.230 |
Why?
| | Bronchodilator Agents | 1 | 2006 | 195 | 0.230 |
Why?
| | Disease Progression | 3 | 2024 | 2730 | 0.220 |
Why?
| | Receptors, CCR2 | 1 | 2023 | 39 | 0.210 |
Why?
| | Fibrosis | 2 | 2024 | 544 | 0.210 |
Why?
| | Hernia, Diaphragmatic | 1 | 2003 | 66 | 0.210 |
Why?
| | Deglutition | 1 | 2024 | 71 | 0.210 |
Why?
| | Pleural Effusion | 1 | 2003 | 55 | 0.200 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 351 | 0.200 |
Why?
| | Severity of Illness Index | 4 | 2020 | 2838 | 0.200 |
Why?
| | Biomarkers | 5 | 2019 | 4111 | 0.190 |
Why?
| | Thyroid Nuclear Factor 1 | 3 | 2019 | 15 | 0.190 |
Why?
| | Bronchoscopy | 3 | 2018 | 218 | 0.190 |
Why?
| | Self-Evaluation Programs | 2 | 1999 | 6 | 0.180 |
Why?
| | Arthritis, Juvenile | 2 | 2019 | 54 | 0.180 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2024 | 229 | 0.180 |
Why?
| | Education, Medical | 1 | 2005 | 273 | 0.180 |
Why?
| | Immunocompromised Host | 2 | 2015 | 204 | 0.170 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2022 | 98 | 0.170 |
Why?
| | Stevens-Johnson Syndrome | 1 | 2021 | 39 | 0.170 |
Why?
| | Protein C | 1 | 2021 | 51 | 0.170 |
Why?
| | Heart Defects, Congenital | 3 | 2018 | 840 | 0.170 |
Why?
| | Indoles | 1 | 2024 | 408 | 0.170 |
Why?
| | Pulmonary Medicine | 2 | 2019 | 81 | 0.160 |
Why?
| | Thinking | 1 | 2001 | 68 | 0.160 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 2000 | 72 | 0.160 |
Why?
| | Proteolipids | 2 | 2000 | 30 | 0.160 |
Why?
| | Foundations | 2 | 2020 | 30 | 0.160 |
Why?
| | Heart Diseases | 1 | 2023 | 331 | 0.160 |
Why?
| | Respiratory Rate | 1 | 2019 | 19 | 0.150 |
Why?
| | Athetosis | 1 | 2019 | 7 | 0.150 |
Why?
| | Congenital Hypothyroidism | 1 | 2019 | 11 | 0.150 |
Why?
| | Chorea | 1 | 2019 | 13 | 0.150 |
Why?
| | Genetic Predisposition to Disease | 3 | 2019 | 2374 | 0.150 |
Why?
| | Infant, Newborn, Diseases | 1 | 2001 | 113 | 0.150 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2019 | 16 | 0.150 |
Why?
| | Digestive System Diseases | 1 | 2019 | 26 | 0.150 |
Why?
| | Societies | 1 | 2019 | 39 | 0.150 |
Why?
| | User-Computer Interface | 3 | 2006 | 162 | 0.150 |
Why?
| | Preceptorship | 1 | 1999 | 67 | 0.150 |
Why?
| | Registries | 2 | 2025 | 2059 | 0.150 |
Why?
| | Air | 1 | 2018 | 41 | 0.140 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2019 | 117 | 0.140 |
Why?
| | Oximetry | 1 | 2019 | 109 | 0.140 |
Why?
| | Colorado | 6 | 2019 | 4553 | 0.140 |
Why?
| | Bronchi | 2 | 2015 | 267 | 0.140 |
Why?
| | Educational Measurement | 1 | 2001 | 290 | 0.140 |
Why?
| | Models, Anatomic | 1 | 2018 | 84 | 0.140 |
Why?
| | Esophageal Mucosa | 1 | 2018 | 22 | 0.140 |
Why?
| | Radiography | 3 | 2013 | 846 | 0.140 |
Why?
| | Virtual Reality | 1 | 2019 | 65 | 0.140 |
Why?
| | Fibroblast Growth Factor 1 | 2 | 1996 | 13 | 0.140 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 109 | 0.140 |
Why?
| | Pneumonia, Lipid | 1 | 2017 | 3 | 0.140 |
Why?
| | Respiratory Sounds | 2 | 2010 | 109 | 0.140 |
Why?
| | Respiration | 1 | 2018 | 206 | 0.130 |
Why?
| | Adult | 14 | 2024 | 38063 | 0.130 |
Why?
| | Arteriovenous Anastomosis | 1 | 2017 | 13 | 0.130 |
Why?
| | Bronchial Arteries | 1 | 2017 | 12 | 0.130 |
Why?
| | Research Design | 2 | 2023 | 1122 | 0.130 |
Why?
| | Autophagy | 2 | 2022 | 286 | 0.130 |
Why?
| | Polysomnography | 1 | 2018 | 203 | 0.130 |
Why?
| | Lymphocytes | 1 | 2019 | 392 | 0.130 |
Why?
| | Prognosis | 6 | 2024 | 3982 | 0.130 |
Why?
| | Down Syndrome | 1 | 2023 | 486 | 0.130 |
Why?
| | Gastroesophageal Reflux | 2 | 2015 | 240 | 0.130 |
Why?
| | Internal Medicine | 1 | 1999 | 271 | 0.130 |
Why?
| | Gastrostomy | 1 | 2018 | 117 | 0.130 |
Why?
| | Membrane Proteins | 2 | 2022 | 1154 | 0.130 |
Why?
| | Disease Management | 3 | 2019 | 620 | 0.130 |
Why?
| | Pulmonary Artery | 2 | 2024 | 1108 | 0.120 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2019 | 281 | 0.120 |
Why?
| | Bleomycin | 1 | 1997 | 248 | 0.120 |
Why?
| | Mutation, Missense | 2 | 2014 | 340 | 0.120 |
Why?
| | Esophageal Atresia | 1 | 2015 | 26 | 0.120 |
Why?
| | Pulmonary Surgical Procedures | 1 | 2015 | 7 | 0.120 |
Why?
| | Clinical Competence | 3 | 2018 | 1123 | 0.120 |
Why?
| | Young Adult | 8 | 2019 | 13329 | 0.120 |
Why?
| | Lung Transplantation | 2 | 2015 | 314 | 0.120 |
Why?
| | Tracheoesophageal Fistula | 1 | 2015 | 33 | 0.120 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2015 | 34 | 0.120 |
Why?
| | Thyroid Gland | 1 | 2015 | 91 | 0.120 |
Why?
| | Imaging, Three-Dimensional | 2 | 2017 | 564 | 0.120 |
Why?
| | Heart Rate | 1 | 2019 | 800 | 0.120 |
Why?
| | Comorbidity | 1 | 2020 | 1638 | 0.110 |
Why?
| | Pregnancy Trimester, First | 1 | 2015 | 137 | 0.110 |
Why?
| | Patient Satisfaction | 2 | 2019 | 681 | 0.110 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 491 | 0.110 |
Why?
| | Family Practice | 1 | 1999 | 462 | 0.110 |
Why?
| | Gestational Age | 1 | 2018 | 915 | 0.110 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 1032 | 0.110 |
Why?
| | Pluripotent Stem Cells | 1 | 2015 | 80 | 0.110 |
Why?
| | Patient Care Team | 2 | 2018 | 637 | 0.110 |
Why?
| | Angiography | 1 | 2015 | 209 | 0.110 |
Why?
| | Delayed Diagnosis | 1 | 2015 | 90 | 0.110 |
Why?
| | Genetic Diseases, Inborn | 1 | 2014 | 44 | 0.110 |
Why?
| | Forced Expiratory Volume | 3 | 2024 | 481 | 0.110 |
Why?
| | Chest Tubes | 1 | 2014 | 29 | 0.110 |
Why?
| | Phenotype | 3 | 2018 | 3158 | 0.110 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2014 | 45 | 0.110 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 748 | 0.110 |
Why?
| | Electric Impedance | 3 | 2018 | 109 | 0.110 |
Why?
| | Cell Differentiation | 3 | 2015 | 1999 | 0.100 |
Why?
| | Diagnostic Techniques, Respiratory System | 1 | 2013 | 5 | 0.100 |
Why?
| | Deglutition Disorders | 1 | 2015 | 148 | 0.100 |
Why?
| | Blood Proteins | 1 | 2015 | 246 | 0.100 |
Why?
| | Societies, Medical | 2 | 2019 | 820 | 0.100 |
Why?
| | Regeneration | 1 | 2015 | 198 | 0.100 |
Why?
| | Abnormalities, Multiple | 1 | 2015 | 195 | 0.100 |
Why?
| | Airway Obstruction | 1 | 2015 | 157 | 0.100 |
Why?
| | DNA Mutational Analysis | 2 | 2013 | 398 | 0.100 |
Why?
| | Homozygote | 1 | 2013 | 203 | 0.100 |
Why?
| | Ambulatory Care | 1 | 2018 | 571 | 0.100 |
Why?
| | Autoimmunity | 1 | 2019 | 899 | 0.100 |
Why?
| | Treatment Outcome | 6 | 2015 | 10832 | 0.100 |
Why?
| | Glycoproteins | 2 | 2000 | 357 | 0.100 |
Why?
| | Device Removal | 1 | 2014 | 135 | 0.100 |
Why?
| | Pedigree | 2 | 2013 | 511 | 0.100 |
Why?
| | Evidence-Based Medicine | 1 | 2017 | 743 | 0.100 |
Why?
| | Follow-Up Studies | 4 | 2019 | 5144 | 0.100 |
Why?
| | Schools, Medical | 2 | 2007 | 151 | 0.100 |
Why?
| | Software | 1 | 1998 | 665 | 0.100 |
Why?
| | Autoantibodies | 3 | 2019 | 1454 | 0.100 |
Why?
| | Mucin-5B | 1 | 2015 | 225 | 0.100 |
Why?
| | Plethysmography | 1 | 2012 | 108 | 0.100 |
Why?
| | Familial Primary Pulmonary Hypertension | 2 | 2024 | 198 | 0.090 |
Why?
| | Fibroblast Growth Factor 7 | 5 | 2000 | 15 | 0.090 |
Why?
| | Fibroblast Growth Factor 10 | 5 | 2000 | 23 | 0.090 |
Why?
| | Leukocytes | 1 | 2013 | 307 | 0.090 |
Why?
| | Critical Care | 1 | 2017 | 615 | 0.090 |
Why?
| | World Health Organization | 1 | 2012 | 126 | 0.090 |
Why?
| | Cardiac Catheterization | 1 | 2015 | 514 | 0.090 |
Why?
| | Spirometry | 1 | 2012 | 261 | 0.090 |
Why?
| | Premature Birth | 1 | 2015 | 340 | 0.090 |
Why?
| | Models, Statistical | 1 | 2015 | 665 | 0.090 |
Why?
| | Hydrocortisone | 1 | 1994 | 310 | 0.090 |
Why?
| | Genetic Counseling | 2 | 2015 | 79 | 0.090 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 85 | 0.090 |
Why?
| | Bronchoalveolar Lavage | 3 | 2007 | 91 | 0.090 |
Why?
| | Bromhexine | 1 | 2010 | 1 | 0.090 |
Why?
| | Internship and Residency | 2 | 2018 | 1173 | 0.090 |
Why?
| | Laryngeal Diseases | 1 | 2011 | 30 | 0.090 |
Why?
| | Rats, Sprague-Dawley | 5 | 1997 | 2472 | 0.090 |
Why?
| | Physicians | 1 | 2019 | 929 | 0.090 |
Why?
| | Granulomatosis with Polyangiitis | 1 | 2011 | 45 | 0.090 |
Why?
| | Epithelial Cells | 4 | 2015 | 1100 | 0.080 |
Why?
| | Rituximab | 1 | 2011 | 174 | 0.080 |
Why?
| | Syndrome | 1 | 2011 | 377 | 0.080 |
Why?
| | Rats | 8 | 2000 | 5564 | 0.080 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2011 | 97 | 0.080 |
Why?
| | Endoscopy, Digestive System | 2 | 2024 | 135 | 0.080 |
Why?
| | Intestinal Mucosa | 1 | 2015 | 621 | 0.080 |
Why?
| | Nuclear Proteins | 2 | 2013 | 709 | 0.080 |
Why?
| | Diagnostic Imaging | 2 | 2015 | 329 | 0.080 |
Why?
| | Referral and Consultation | 1 | 2015 | 797 | 0.080 |
Why?
| | Uniparental Disomy | 1 | 2009 | 9 | 0.080 |
Why?
| | Microscopy, Electron | 3 | 2013 | 435 | 0.080 |
Why?
| | Esophagus | 2 | 2024 | 255 | 0.080 |
Why?
| | Anti-Bacterial Agents | 2 | 2013 | 1804 | 0.080 |
Why?
| | Uteroglobin | 2 | 2000 | 22 | 0.080 |
Why?
| | Mucin-1 | 1 | 2009 | 21 | 0.080 |
Why?
| | Lipid Metabolism, Inborn Errors | 1 | 2009 | 18 | 0.080 |
Why?
| | Body Mass Index | 1 | 2017 | 2422 | 0.070 |
Why?
| | Cell Division | 4 | 2000 | 790 | 0.070 |
Why?
| | Neutrophils | 1 | 2013 | 1270 | 0.070 |
Why?
| | DNA | 2 | 2013 | 1448 | 0.070 |
Why?
| | Cytogenetic Analysis | 1 | 2007 | 33 | 0.070 |
Why?
| | Medical History Taking | 2 | 2005 | 117 | 0.070 |
Why?
| | Lung Volume Measurements | 1 | 2007 | 46 | 0.070 |
Why?
| | Nebulizers and Vaporizers | 1 | 2007 | 66 | 0.070 |
Why?
| | Transcription Factors | 2 | 2013 | 1709 | 0.060 |
Why?
| | Respiratory Tract Infections | 1 | 2011 | 384 | 0.060 |
Why?
| | DNA, Bacterial | 1 | 2007 | 337 | 0.060 |
Why?
| | Logistic Models | 3 | 2015 | 2081 | 0.060 |
Why?
| | Cough | 1 | 2007 | 125 | 0.060 |
Why?
| | Delphi Technique | 2 | 2018 | 278 | 0.060 |
Why?
| | Consensus | 2 | 2020 | 676 | 0.060 |
Why?
| | Computer-Assisted Instruction | 1 | 2006 | 69 | 0.060 |
Why?
| | Receptors, Purinergic P2Y2 | 1 | 2005 | 4 | 0.060 |
Why?
| | Administration, Inhalation | 2 | 2005 | 588 | 0.060 |
Why?
| | Animals | 12 | 2019 | 37151 | 0.060 |
Why?
| | Cross-Sectional Studies | 2 | 2015 | 5556 | 0.060 |
Why?
| | Respiratory Mucosa | 2 | 2014 | 320 | 0.060 |
Why?
| | Prospective Studies | 4 | 2023 | 7603 | 0.060 |
Why?
| | Intraoperative Period | 2 | 2015 | 60 | 0.060 |
Why?
| | Age Distribution | 1 | 2005 | 400 | 0.060 |
Why?
| | Faculty, Medical | 1 | 2007 | 289 | 0.050 |
Why?
| | Program Evaluation | 2 | 2019 | 912 | 0.050 |
Why?
| | Teaching | 1 | 2006 | 231 | 0.050 |
Why?
| | Age of Onset | 1 | 2005 | 522 | 0.050 |
Why?
| | Pulmonary Veno-Occlusive Disease | 1 | 2003 | 12 | 0.050 |
Why?
| | T-Box Domain Proteins | 1 | 2024 | 98 | 0.050 |
Why?
| | Patient Simulation | 1 | 2003 | 37 | 0.050 |
Why?
| | Methylprednisolone | 2 | 2013 | 63 | 0.050 |
Why?
| | Macrophages, Alveolar | 2 | 2023 | 396 | 0.050 |
Why?
| | Autophagy-Related Proteins | 1 | 2022 | 46 | 0.050 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2022 | 52 | 0.050 |
Why?
| | Cohort Studies | 3 | 2023 | 5731 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2024 | 410 | 0.050 |
Why?
| | Neuroblastoma | 1 | 2003 | 160 | 0.050 |
Why?
| | Bone Marrow Transplantation | 1 | 2003 | 288 | 0.050 |
Why?
| | Data Collection | 1 | 2005 | 667 | 0.050 |
Why?
| | Terminology as Topic | 2 | 2018 | 246 | 0.050 |
Why?
| | Vesicular Transport Proteins | 1 | 2022 | 85 | 0.050 |
Why?
| | Genotype | 2 | 2018 | 1876 | 0.040 |
Why?
| | Herpesvirus 4, Human | 1 | 2022 | 165 | 0.040 |
Why?
| | Cross-Cultural Comparison | 1 | 2001 | 86 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 235 | 0.040 |
Why?
| | Bacteria | 1 | 2007 | 873 | 0.040 |
Why?
| | Disease Models, Animal | 3 | 2019 | 4309 | 0.040 |
Why?
| | Surface-Active Agents | 1 | 2021 | 91 | 0.040 |
Why?
| | RNA, Messenger | 4 | 2000 | 2799 | 0.040 |
Why?
| | Combined Modality Therapy | 2 | 2015 | 1234 | 0.040 |
Why?
| | Group Processes | 1 | 2001 | 66 | 0.040 |
Why?
| | Models, Educational | 1 | 2001 | 93 | 0.040 |
Why?
| | Pulmonary Surfactant-Associated Proteins | 2 | 2000 | 10 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2015 | 1718 | 0.040 |
Why?
| | Neoplasms | 1 | 2015 | 2712 | 0.040 |
Why?
| | Pemphigus | 1 | 1999 | 9 | 0.040 |
Why?
| | Heart | 1 | 2023 | 611 | 0.040 |
Why?
| | Paraneoplastic Syndromes | 1 | 1999 | 12 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 568 | 0.040 |
Why?
| | Developing Countries | 1 | 2001 | 312 | 0.040 |
Why?
| | Speech-Language Pathology | 1 | 2019 | 23 | 0.040 |
Why?
| | Incidence | 2 | 2019 | 2827 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 2 | 2013 | 470 | 0.040 |
Why?
| | Pulmonary Surfactant-Associated Protein D | 2 | 2000 | 35 | 0.040 |
Why?
| | Esophageal pH Monitoring | 1 | 2018 | 23 | 0.040 |
Why?
| | Survival Rate | 2 | 2019 | 1912 | 0.040 |
Why?
| | Hospital Information Systems | 1 | 1998 | 15 | 0.040 |
Why?
| | NF-kappa B | 1 | 2022 | 679 | 0.040 |
Why?
| | Formative Feedback | 1 | 2018 | 28 | 0.040 |
Why?
| | Computer Communication Networks | 1 | 1998 | 34 | 0.040 |
Why?
| | Alveolar Epithelial Cells | 1 | 2019 | 114 | 0.040 |
Why?
| | Efficiency, Organizational | 1 | 2019 | 140 | 0.030 |
Why?
| | Interdisciplinary Research | 1 | 2018 | 27 | 0.030 |
Why?
| | Students, Medical | 1 | 2002 | 356 | 0.030 |
Why?
| | Otolaryngology | 1 | 2019 | 93 | 0.030 |
Why?
| | Drug Antagonism | 1 | 1997 | 10 | 0.030 |
Why?
| | Hydroxyproline | 1 | 1997 | 20 | 0.030 |
Why?
| | Fundoplication | 1 | 1997 | 57 | 0.030 |
Why?
| | Receptor Protein-Tyrosine Kinases | 2 | 1996 | 231 | 0.030 |
Why?
| | Macrophage Activation Syndrome | 1 | 2017 | 22 | 0.030 |
Why?
| | Gene Expression | 3 | 2000 | 1487 | 0.030 |
Why?
| | Information Storage and Retrieval | 1 | 1998 | 118 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2018 | 238 | 0.030 |
Why?
| | Review Literature as Topic | 1 | 2017 | 74 | 0.030 |
Why?
| | Hydrochloric Acid | 1 | 1996 | 9 | 0.030 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 1996 | 27 | 0.030 |
Why?
| | Cholera Toxin | 1 | 1996 | 31 | 0.030 |
Why?
| | Trachea | 1 | 2018 | 249 | 0.030 |
Why?
| | Gastroenterology | 1 | 2019 | 178 | 0.030 |
Why?
| | Endoplasmic Reticulum | 1 | 2019 | 269 | 0.030 |
Why?
| | Receptors, Fibroblast Growth Factor | 1 | 1996 | 68 | 0.030 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 244 | 0.030 |
Why?
| | Analysis of Variance | 1 | 1999 | 1311 | 0.030 |
Why?
| | Monitoring, Physiologic | 1 | 2018 | 270 | 0.030 |
Why?
| | Culture Media | 1 | 1996 | 164 | 0.030 |
Why?
| | Organ Size | 1 | 1997 | 473 | 0.030 |
Why?
| | Cyclic AMP | 1 | 1996 | 219 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2023 | 2861 | 0.030 |
Why?
| | Xenopus | 1 | 2015 | 88 | 0.030 |
Why?
| | Respiratory Insufficiency | 1 | 1999 | 317 | 0.030 |
Why?
| | Sampling Studies | 1 | 2015 | 101 | 0.030 |
Why?
| | Embryonic Induction | 1 | 1995 | 31 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2019 | 518 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2015 | 193 | 0.030 |
Why?
| | Laminin | 1 | 1995 | 72 | 0.030 |
Why?
| | Health Services Research | 1 | 2018 | 408 | 0.030 |
Why?
| | Mouth | 1 | 2015 | 87 | 0.030 |
Why?
| | Ventilator-Induced Lung Injury | 1 | 2015 | 56 | 0.030 |
Why?
| | Autophagy-Related Protein 8 Family | 1 | 2014 | 2 | 0.030 |
Why?
| | Vimentin | 1 | 1995 | 52 | 0.030 |
Why?
| | Proteostasis Deficiencies | 1 | 2014 | 5 | 0.030 |
Why?
| | Demography | 1 | 2015 | 295 | 0.030 |
Why?
| | Sequestosome-1 Protein | 1 | 2014 | 15 | 0.030 |
Why?
| | Long-Term Care | 1 | 2015 | 106 | 0.030 |
Why?
| | Gene Expression Regulation | 2 | 2014 | 2586 | 0.030 |
Why?
| | Mice | 3 | 2019 | 17769 | 0.030 |
Why?
| | Hepatocyte Growth Factor | 1 | 1994 | 35 | 0.030 |
Why?
| | Proteoglycans | 1 | 1995 | 110 | 0.030 |
Why?
| | Vacuoles | 1 | 2014 | 41 | 0.030 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2014 | 73 | 0.030 |
Why?
| | North America | 1 | 2015 | 309 | 0.030 |
Why?
| | Fatal Outcome | 2 | 2009 | 309 | 0.030 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2015 | 137 | 0.030 |
Why?
| | Mesoderm | 1 | 1995 | 144 | 0.030 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2015 | 194 | 0.030 |
Why?
| | Drug Combinations | 1 | 1995 | 341 | 0.030 |
Why?
| | Prevalence | 2 | 2011 | 2762 | 0.030 |
Why?
| | Culture Techniques | 1 | 1994 | 73 | 0.030 |
Why?
| | Cardiovascular Agents | 1 | 2015 | 155 | 0.030 |
Why?
| | Lysosomes | 1 | 2014 | 145 | 0.030 |
Why?
| | rab GTP-Binding Proteins | 1 | 2014 | 76 | 0.030 |
Why?
| | ROC Curve | 1 | 2015 | 563 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2019 | 652 | 0.030 |
Why?
| | Embryonic and Fetal Development | 1 | 1994 | 95 | 0.030 |
Why?
| | Consanguinity | 1 | 2013 | 49 | 0.030 |
Why?
| | Microfilament Proteins | 1 | 2014 | 133 | 0.030 |
Why?
| | Rats, Inbred F344 | 3 | 2000 | 267 | 0.030 |
Why?
| | B-Lymphocytes | 1 | 2019 | 849 | 0.030 |
Why?
| | Genes, Recessive | 1 | 2013 | 78 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2014 | 307 | 0.030 |
Why?
| | Hydroxychloroquine | 1 | 2013 | 56 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 1995 | 1088 | 0.030 |
Why?
| | Drainage | 1 | 2014 | 173 | 0.030 |
Why?
| | Microtubule-Associated Proteins | 1 | 2014 | 195 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 2014 | 169 | 0.030 |
Why?
| | Laparoscopy | 1 | 1997 | 445 | 0.030 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2014 | 175 | 0.030 |
Why?
| | Azithromycin | 1 | 2013 | 98 | 0.020 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2015 | 201 | 0.020 |
Why?
| | Siblings | 1 | 2013 | 216 | 0.020 |
Why?
| | Maternal-Fetal Exchange | 1 | 1994 | 165 | 0.020 |
Why?
| | Transcriptome | 1 | 2019 | 969 | 0.020 |
Why?
| | Collagen | 1 | 1995 | 454 | 0.020 |
Why?
| | Stem Cell Transplantation | 1 | 2013 | 178 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1639 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2014 | 730 | 0.020 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2015 | 309 | 0.020 |
Why?
| | Pregnancy | 2 | 2015 | 6789 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2019 | 3014 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 33509 | 0.020 |
Why?
| | Congresses as Topic | 1 | 2013 | 228 | 0.020 |
Why?
| | Algorithms | 2 | 2015 | 1711 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2014 | 430 | 0.020 |
Why?
| | Pain, Postoperative | 1 | 2014 | 281 | 0.020 |
Why?
| | Dexamethasone | 1 | 1994 | 365 | 0.020 |
Why?
| | Denmark | 1 | 2011 | 46 | 0.020 |
Why?
| | Risk Factors | 2 | 2015 | 10433 | 0.020 |
Why?
| | Granuloma | 1 | 2011 | 96 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2019 | 1983 | 0.020 |
Why?
| | Laryngostenosis | 1 | 2011 | 50 | 0.020 |
Why?
| | Cells, Cultured | 2 | 1995 | 4160 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2015 | 895 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2015 | 1237 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2015 | 2166 | 0.020 |
Why?
| | Cell Line | 1 | 2015 | 2865 | 0.020 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2009 | 27 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2014 | 535 | 0.020 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2009 | 36 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1751 | 0.020 |
Why?
| | Specific Pathogen-Free Organisms | 2 | 2000 | 60 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5769 | 0.020 |
Why?
| | DNA Methylation | 1 | 2013 | 641 | 0.020 |
Why?
| | Mitochondria | 1 | 2014 | 951 | 0.020 |
Why?
| | Time Factors | 1 | 2019 | 6845 | 0.020 |
Why?
| | Genes, rRNA | 1 | 2007 | 42 | 0.020 |
Why?
| | Genes, Bacterial | 1 | 2007 | 166 | 0.020 |
Why?
| | Endocrine System Diseases | 1 | 2007 | 35 | 0.020 |
Why?
| | Biomedical Research | 1 | 2014 | 703 | 0.020 |
Why?
| | Growth Disorders | 1 | 2007 | 87 | 0.020 |
Why?
| | Risk Assessment | 1 | 2015 | 3471 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 1029 | 0.010 |
Why?
| | Chronic Disease | 1 | 2011 | 1791 | 0.010 |
Why?
| | Nervous System Diseases | 1 | 2007 | 273 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2015 | 2671 | 0.010 |
Why?
| | CD-ROM | 1 | 2003 | 6 | 0.010 |
Why?
| | Teaching Materials | 1 | 2003 | 24 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2007 | 2925 | 0.010 |
Why?
| | Signal Transduction | 1 | 1996 | 5068 | 0.010 |
Why?
| | Proteins | 2 | 2000 | 1011 | 0.010 |
Why?
| | Inflammation | 1 | 2014 | 2847 | 0.010 |
Why?
| | Transplantation, Autologous | 1 | 2003 | 242 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2003 | 424 | 0.010 |
Why?
| | Korea | 1 | 2001 | 17 | 0.010 |
Why?
| | Adenovirus Infections, Human | 1 | 2001 | 15 | 0.010 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2001 | 56 | 0.010 |
Why?
| | Bromodeoxyuridine | 1 | 2000 | 78 | 0.010 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2000 | 35 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2000 | 318 | 0.010 |
Why?
| | Acantholysis | 1 | 1999 | 2 | 0.010 |
Why?
| | Castleman Disease | 1 | 1999 | 13 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 2003 | 1371 | 0.010 |
Why?
| | Epithelium | 1 | 1999 | 316 | 0.010 |
Why?
| | Internet | 1 | 2003 | 681 | 0.010 |
Why?
| | Lymphoma, B-Cell | 1 | 1999 | 112 | 0.010 |
Why?
| | Adolescent Behavior | 1 | 2003 | 533 | 0.010 |
Why?
| | Phospholipases A | 1 | 1997 | 104 | 0.010 |
Why?
| | Physical Examination | 1 | 1998 | 243 | 0.010 |
Why?
| | Clinical Protocols | 1 | 1998 | 267 | 0.010 |
Why?
| | Cell Count | 1 | 1996 | 318 | 0.010 |
Why?
| | Influenza, Human | 1 | 2001 | 611 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 1999 | 901 | 0.010 |
Why?
| | Attitude of Health Personnel | 1 | 2002 | 1157 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 1994 | 73 | 0.010 |
Why?
| | Age Factors | 1 | 2000 | 3285 | 0.010 |
Why?
|
|
Deterding's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|